Phase I study of tauromustine administered in a weekly schedule.

[1]  J. Bergh,et al.  Phase II study of tauromustine in disseminated malignant melanoma. , 1989, European journal of cancer & clinical oncology.

[2]  J. S. Macpherson,et al.  Phase I study of TCNU, a novel nitrosourea. , 1987, European journal of cancer & clinical oncology.

[3]  D. Schwalm,et al.  Phase I evaluation of semustine in a weekly schedule. , 1983, Cancer treatment reports.

[4]  J. Edmonson,et al.  Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. , 1965, Cancer research.

[5]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .